Cell-cell fusion events were measured using an IncuCyte (Sartorious) and determined as the proportion of merged area to green area over time
Reference: CJC-1295 (No DAC) Protocol Page

Description Ingredients: Purified water, butylene glycol, beeswax, caprylic/capric triglyceride, niacinamide, cetearyl alcohol, isononyl isononanoate, arachidyl alcohol, 1,2-hexanediol, polyglyceryl-3 methylglucose distearate, behenyl alcohol, glyceryl stearate, betaine, arachidyl glucoside, allantoin, sorbitan oleate, panthenol, hydrogenated lecithin, tocopherol, xanthan gum, glycerin, Glutathione (600 ppm), ethylhexylglycerin, dipotassium glycyrrhizate, stearic acid, disodium EDTA, bisabolol, sodium hyaluronate, ascorbyl tetraisopalmitate, glucose, balm leaf extract, ladys mantle extract, yarrow extract, speedwell extract, peppermint leaf extract, evening primrose extract, polyglyceryl-10 stearate, ceramide NP, sodium ascorbyl phosphate, ceramide NS, cholesterol, phytosphingosine, ceramide AP, ceramide AS, sodium hydroxide, biotin, acetyl hexapeptide-8, copper tripeptide-1, pyridoxine, oligopeptide-29, oligopeptide-32, cyanocobalamine, palmitoyl pentapeptide-4, ceramide EP, riboflavin, beta-carotene, thiamine HCL, fragrance.

Published Research Context Research on Ipamorelin referenced in clinical literature includes animal studies demonstrating GH release stimulation, limited human pharmacokinetic studies establishing dosing parameters, and research examining Ipamorelin's effects on gastrointestinal motility, where it has shown particular interest for post-operative applications
PMID 12835357